Trial Profile
A Retrospective Study of Sofosbuvir/Ledipasvir Therapy in Hepatitis C virus (HCV) and Human-Immunodeficiency Virus (HIV) Co-Infected Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 24 Oct 2017 New trial record
- 08 Oct 2017 Results presented at the IDWeek 2017.